Company Overview

Update
Status:
Acquired by Forest Laboratories
Founded:
1998
Employees:
24
Headquarters:
Morrisville, NC
IPO:
Went Public on Jun 11, 2010
Stock:
FURX
Categories:
Biotechnology
Description:
Furiex Pharmaceuticals is a drug development collaboration company focused on improving the value of partnered drug programs.

Detailed Description

Update

Furiex Pharmaceuticals, Inc., a drug development company, engages in the compound partnering business primarily in the United States. It collaborates with pharmaceutical and biotechnology companies to enhance the value of their drug candidates by applying its novel approach to drug development. The company’s products under development include Eluxadoline1, a mu opioid receptor agonist and delta opioid receptor antagonist, which is in Phase III clinical trials for the treatment of diarrhea-predominant irritable bowel syndrome; and Avarofloxacin1, a Phase III-ready fluoroquinolone antibiotic for the treatment of acute bacterial skin and skin structure infections.

Current Team (15)

Update

Past Team (1)

Update

Funding Rounds (1) - $15M

Update

Board Members and Advisors (3)

Update

Offices/Locations (1)

Update
  • Office

    3900 Paramount Parkway

    Suite 150

    Morrisville, NC 27560

    USA

Images (1)

Update
  • Eqfu5jrb9hcyc8lfki76